1.16BMarket Cap-6444P/E (TTM)
20.310High18.750Low214.39KVolume18.940Open19.100Pre Close4.24MTurnover0.57%Turnover RatioLossP/E (Static)57.63MShares30.18952wk High2.73P/B757.58MFloat Cap7.64052wk Low--Dividend TTM37.56MShs Float59.850Historical High--Div YieldTTM8.17%Amplitude7.300Historical Low19.786Avg Price1Lot Size
Cullinan Therapeutics Stock Forum
NEWS
Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating Novel Anti-MICA/B Antibody, CLN-619, as Monotherapy and in Combination with a Checkpoint Inhibitor in Patients with Advanced Solid Tumors at ASCO 2024
• $Cullinan Therapeutics(CGEM.US)$ +22.4% (Cullinan Management and Taiho Pharmaceutical to collaborate to jointly develop and commercialize CLN081/TAS6417 and Taiho's acquisition of Cullinan Pearl)
• $Lordstown Motors(RIDE.US)$ +17.2% (closes asset purchase agreement with Foxconn)
• $Applovin(APP.US)$ +15.5%(In reaction to earnings)
• $SmartRent(SMRT.US)$ +15.4%(In reaction to earnings)
• $Coupang(CPNG.US)$ +14.3%(In reaction to earn...
No comment yet